Intra-pleural tissue plasminogen activator and deoxyribonuclease: An alternative treatment option for pleural infections in specific populations
Abstract
Pleural infections can be associated with significant morbidity and mortality. Systemic antibiotics and drainage are the standard treatment, but some patients require surgical intervention for complete resolution. For unsuitable surgical candidates, the intra-pleural administration of tissue plasminogen activator and deoxyribonuclease (tPA/DNase) is a potential treatment option for loculated effusions. We present a case of loculated empyema successfully treated with a 3-day course of once daily intra-pleural administration of tPA/DNase. Considering the frailty of our patient, we choose the once daily tPA/DNase due to concerns about potential complications, such as increased risk of bleeding. The published trial evidence and administration regimens of intra-pleural tPA/DNase are also discussed.
Keywords: tPA/DNAse, loculated pleural effusion, empyema
Downloads
References
Rahman NM, Maskell NA, West A, et al. Intra-pleural use of
tissue plasminogen activator and DNase in pleural infection.
N Engl J Med 2011;365:518–526.
Rahman NM, Kahan BC, Miller RF, et al. A clinical score
(RAPID) to identify those at risk for poor outcome at presentation
in patients with pleural infection. Chest 2014;145:
–855.
Maskell NA, Davies CW, Nunn AJ, et al. for the First Multicenter
Intra-Pleural Sepsis Trial (MIST1) Group. U.K. Controlled
trial of intra-pleural streptokinase for pleural infection.
N Engl J Med 2005;352:865–874.
Piccolo F, Popowicz N, Wong D, et al. Intrapleural tissue plasminogen
activator and deoxyribonuclease therapy for pleural
infection. J Thoracic Disease 2015;7(6):999–1008.
Mehta H J, Biswas A, Penley A M, et al. Management of
intra-pleural sepsis with once daily use of tissue plasminogen
activator and deoxyribonuclease. Respiration 2016; 91:101–106.
